Startup Uses AI to Develop Biological Weapon Antibodies

Reed Queen Bio is developing antibodies using artificial intelligence to protect against potential pathogens, including influenza viruses and other viruses, with the aim of providing broad-spectrum protection. The company relies on AI technology to design more effective antibodies and plans to conduct human clinical trials next year for drugs against bird flu and other viruses. These efforts come in the context of concerns about the use of artificial intelligence in developing dangerous biological weapons, as the company's founders seek to develop treatments that can more quickly counter future epidemic threats.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل